ABCB1 and ovarian carcinoma: To our knowledge, this is the first report of anticancer synergy using poziotinib in combination with paclitaxel in ovarian cancer, although poziotinib-mediated inhibition of ABCB1 activity was recently reported in colon cancer cells [33].